Détail - canceropole-wordpress

Correlation between MRI, biopsy results and radical prostatectomy histological analysis, application to focal therapy.

Cormier H, Escoffier A, Aho-Glele LS, Funes de la Vega M, Cochet A, Cormier L

Fr J Urol. 2025 05 29;35(6-7):102913

Demographic analysis of penectomies in France from 2019 to 2022.

Escoffier A, Delattre B, Bettler L, Bontemps G, Cormier L

Fr J Urol. 2024 12 5;:102844

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.

Baude J, Niogret J, Jacob P, Bardet F, Desmoulins I, Zanetta S, Kaderbhai C, Galland L, Mayeur D, Delattre B, Cormier L, Ladoire S

Cancers (Basel). 2024 01 9;16(2):

Eliciting men's preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis.

Lejeune C, Bourredjem A, Binquet C, Cussenot O, Boudrant G, Papillon F, Bruyère F, Haillot O, Koutlidis N, Bassard S, Fournier G, Valeri A, Moreau JL, Pierfitte B, Moulin M, Berchi C, Cormier L

World J Urol. 2023 05 12;:

Role of magnetic resonance imaging for preoperative prediction of early biochemical failure in localized prostate cancer.

Cassin J, Walker PM, Blanc J, Asuncion A, Bardet F, Cormier L, Loffroy R, Cochet A

Quant Imaging Med Surg. 2023 03 1;13(3):1440-1452

The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.

Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM, Loos G, Meyer E, Calais G, Peiffert D, Vandendorpe B, Aymes E, Leguillette C, Brihoum M, Nenan S, Cormier L, Le Deley MC, Lartigau EF

Eur Urol Oncol. 2023 02 6;:

[The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].

Brun A, Koutlidis N, Thibault T, Escoffier A, Bardet F, Cormier L

Prog Urol. 2023 01 3;:

Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging.

Asuncion A, Walker PM, Bertaut A, Blanc J, Labarre M, Martin E, Bardet F, Cassin J, Cormier L, Crehange G, Loffroy R, Cochet A

Quant Imaging Med Surg. 2022 12;12(12):5309-5325

Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples.

Marechal E, Jaugey A, Tarris G, Paindavoine M, Seibel J, Martin L, Funes de la Vega M, Crepin T, Ducloux D, Zanetta G, Felix S, Bonnot PH, Bardet F, Cormier L, Rebibou JM, Legendre M

Clin J Am Soc Nephrol. 2021 Dec 3;:

Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.

Deal M, Bardet F, Walker PM, de la Vega MF, Cochet A, Cormier L, Bentellis I, Loffroy R

Quant Imaging Med Surg. 2021 Aug;11(8):3749-3766

[Neurogenic bladder and continent cystostomy: Results of a monocentric cohort in a French university hospital].

Paturel P, Bardet F, Cormier L, Mourey E

Prog Urol. 2021 Jul 10;:

Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?

Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B

Eur Urol. 2021 Jun 26;:

[French ccAFU guidelines - update 2020-2022: prostate cancer].

Rozet F, Mongiat-Artus P, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mathieu R, Ploussard G, Renard-Penna R, Brenot-Rossi I, Bruyere F, Cochet A, Crehange G, Cussenot O, Lebret T, Rebillard X, Soulié M, Brureau L, Méjean A

Prog Urol. 2020 Nov;30(12S):S136-S251

Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression.

Cancel M, Castellier C, Debiais-Delpech C, Charles T, Rozet F, Rioux-Leclercq N, Mathieu R, Beltjens F, Cormier L, Bruyère F, Fromont G

Urol. Oncol.. 2020 Jul 29;:

[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020].

Rozet F, Hennequin C, Beuzeboc P, Mathieu R, Mongiat-Artus P, Beauval JB, Cormier L, Fromont-Hankard G, Ploussard G, Renard-Penna R, Brureau L, Méjean A

Prog. Urol.. 2020 Jun 6;:

[Prostate MRI and screening: Practice survey with general practitioner of the "Bourgogne-Franche Comté" region].

Bardet F, Frontczak A, Schneider A, Delattre B, Kleinclauss F, Cormier L

Prog. Urol.. 2019 Nov 27;:

GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol.

Pasquier D, Le Deley MC, Tresch E, Cormier L, Duterque M, Nenan S, Lartigau E

BMJ Open. 2019 Aug 2;9(8):e026666

Computer-aided diagnosis system for characterizing ISUP grade≥2 prostate cancers at multiparametric MRI: A cross-vendor evaluation.

Transin S, Souchon R, Gonindard-Melodelima C, de Rozario R, Walker P, Funes de la Vega M, Loffroy R, Cormier L, Rouvière O

Diagn Interv Imaging. 2019 Jul 23;:

Patterns of Bone Failure in Localized Prostate Cancer Previously Irradiated: The Preventive Role of External Radiotherapy on Pelvic Bone Metastases.

Grapin M, Quivrin M, Bertaut A, Martin E, Cormier L, Ladoire S, Cochet A, Créhange G

Front Oncol. 2019 ;9:70

[Medico-legal risk in urology: Analysis of a portfolio of insured persons by a French insurance company between 2009 and 2018].

Papillon F, Cormier L, Legeais D

Prog. Urol.. 2018 Nov 14;:

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T

Prog. Urol.. 2018 Nov 1;:

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Renard Penna R, Méjean A

Prog. Urol.. 2018 Nov;28 Suppl 1:R81-R132

Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.

Girum KB, Lalande A, Quivrin M, Bessières I, Pierrat N, Martin E, Cormier L, Petitfils A, Cosset JM, Créhange G

Brachytherapy. 2018 Sep 11;:

Intraoperative cyst rupture of partial nephrectomy for cystic renal masses: does it increase the risk of recurrence?

Pradere B, Peyronnet B, Delporte G, Manach Q, Khene ZE, Moulin M, Roumiguié M, Rizk J, Brichart N, Beauval JB, Cormier L, Bex A, Rouprêt M, Bruyère F, Bensalah K

J. Urol.. 2018 Jun 20;:

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B

N. Engl. J. Med.. 2018 Jun 3;:

Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.

Laclergerie F, Mouillet G, Frontczak A, Balssa L, Eschwege P, Saussine C, Larré S, Cormier L, Vuillemin AT, Kleinclauss F

World J Urol. 2018 Mar;36(3):427-433

Reliability and reproducibility of the American Association for the Surgery of Trauma scaling for renal injury and impact on radiologic follow-up.

Phan QB, Mourey E, Estivalet L, Delattre B, Bardet F, Chevallier O, Louis D, Aho LS, Loffroy R, Cormier L

Prog. Urol.. 2018 Jan;28(1):12-17

[Therapeutic innovations in radiation oncology for localized prostate cancer].

Créhange G, Cormier L

Cancer Radiother. 2017 Sep;:

[Therapeutic innovations in urology for localized prostate cancer].

Cormier L, Créhange G

Cancer Radiother. 2017 Sep;:

[Evaluation of the French practices in brachytherapy using surveys].

Delattre B, Cormier L, Borgogno C, Descotes JL, Peiffert D, Hannoun-Levi JM, Moreau JL

Prog. Urol.. 2017 Jun;:

Monnier L, Culine S, Cormier L

Presse Med. 2017 May;:

(18)F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional T

Kanoun S, Walker P, Vrigneaud JM, Depardon E, Barbier V, Humbert O, Moulin M, Créhange G, Cormier L, Loffroy R, Brunotte F, Cochet A

Int. J. Radiat. Oncol. Biol. Phys.. 2017 Apr;97(5):986-994

[Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].

Léon P, Cancel-Tassin G, Koutlidis N, Calves J, Funes de la Vega M, Fournier G, Valeri A, Cormier L, Larré S, Cussenot O

Prog. Urol.. 2017 Mar;27(3):158-165

Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.

Cornu JN, Audet-Walsh E, Drouin S, Bigot P, Valeri A, Fournier G, Azzouzi AR, Roupret M, Cormier L, Chanock S, Guillemette C, Cussenot O, Lévesque E, Cancel-Tassin G

World J Urol. 2017 Feb;35(2):293-298

Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Bardin F, Chevallier O, Bertaut A, Delorme E, Moulin M, Pottecher P, Di Marco L, Gehin S, Mourey E, Cormier L, Mousson C, Midulla M, Loffroy R

Quant Imaging Med Surg. 2017 Feb;7(1):8-23

Current practice and access to prostate MR imaging in France.

Renard-Penna R, Rouvière O, Puech P, Borgogno C, Abbas L, Roy C, Claudon M, Correas JM, Cormier L, Ploussard G, Mejean A, Tezenas-du-Montcel S, Rozet F

Diagn Interv Imaging. 2016 Nov;97(11):1125-1129

[CCAFU french national guidelines 2016-2018 on prostate cancer].

Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont G, Mongiat-Artus P, Ouzzane A, Ploussard G, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Lebret T, Rebillard X, Soulié M, Renard-Penna R, Méjean A

Prog. Urol.. 2016 Nov;27 Suppl 1:S95-S143

Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.

Cornu JN, Cancel-Tassin G, Cox DG, Roupret M, Koutlidis N, Bigot P, Valeri A, Ondet V, Gaffory C, Fournier G, Azzouzi AR, Cormier L, Cussenot O

Eur. Urol.. 2016 Jul;70(1):6-8

Management of Testicular Silicone Gel-Filled Prosthesis Rupture: Case Report of a Rare Event and a Review of the Literature.

Phan QB, Koutlidis N, Duperron C, Mourey E, Michel F, Cormier L

Case Rep Urol. 2016 ;2016:2824802

Comparison of three different embolic materials for varicocele embolization: retrospective study of tolerance, radiation and recurrence rate.

Favard N, Moulin M, Fauque P, Bertaut A, Favelier S, Estivalet L, Michel F, Cormier L, Sagot P, Loffroy R

Quant Imaging Med Surg. 2015 Dec;5(6):806-14

[Half-day case robotic radical prostatectomy. Surgery of the future? A case report].

Leclers F, Dutheil V, Poupot D, Moalic R, Gosseine PN, Cormier L, Bierman D

Prog Urol. 2015 Nov 13. pii: S1166-7087(15)00638-7

[In Process Citation].

Barbier V, Hardy J, Kanoun S, Cochet A, Arnould L, Crehange G, Cormier L

Prog Urol. 2015 Nov;25(13):733

[In Process Citation].

Laclergerie F, Mouillet G, Larre S, Eschwege P, Hubert J, Saussine C, Cormier L, Thiery-Vuillemin A, Kleinclauss F

Prog Urol. 2015 Nov;25(13):855-6

Current role of multiparametric magnetic resonance imaging for prostate cancer.

Loffroy R, Chevallier O, Moulin M, Favelier S, Genson PY, Pottecher P, Crehange G, Cochet A, Cormier L

Quant Imaging Med Surg. 2015 Oct;5(5):754-64

Image-guided percutaneous microwave ablation of small renal tumours: short- and mid-term outcomes.

Genson PY, Mourey E, Moulin M, Favelier S, Di Marco L, Chevallier O, Cercueil JP, Krausé D, Cormier L, Loffroy R

Quant Imaging Med Surg. 2015 Oct;5(5):649-55

Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.

Quivrin M, Loffroy R, Cormier L, Mazoyer F, Bertaut A, Chambade D, Martin E, Maingon P, Walker P, Crehange G

Radiother Oncol. 2015 Aug 28. pii: S0167-8140(15)00445-4

[High-risk prostate cancer surgical margins during robot-assisted radical prostatectomy].

Duperron C, Moulin M, Koutlidis N, Mourey E, Cormier L

Prog Urol. 2015 Mar 7. pii: S1166-7087(15)00041-X

[Imagery of treated prostate cancer.]

Renard-Penna R, Michaud L, Cormier L, Bastide C, Beuzeboc P, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Rozet F, Richaud P, Salomon L, Soulie M

Prog Urol. 2015 Jan 13. pii: S1166-7087(14)00689-7

[Management of low-risk prostate cancer].

Rozet F, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Renard-Penna R, Richaud P, Salomon L, Soulie M

Prog Urol. 2015 Jan;25(1):1-10

Current role of transcatheter arterial embolization for bladder and prostate hemorrhage.

Loffroy R, Pottecher P, Cherblanc V, Favelier S, Estivalet L, Koutlidis N, Moulin M, Cercueil JP, Cormier L, Krause D

Diagn Interv Imaging. 2014 Nov;95(11):1027-34

[In Process Citation].

Moulin M, Fourcade A, Phan Q, Mege J, Valeri A, Mourey E, Fournier G, Cormier L

Prog Urol. 2014 Nov;24(13):785

[In Process Citation].

Leon P, Kloutidis N, Calves J, Comperat E, Funes de la Vega M, Cancel Tassin G, Ciofu C, Haab F, Fournier G, Korman P, Valeri A, Roupret M, Cormier L, Larre S, Cussenot O

Prog Urol. 2014 Nov;24(13):784

Capsular incision in normal prostatic tissue during robot-assisted radical prostatectomy: a new concept or a waste of time?

Koutlidis N, Duperron C, de la Vega MF, Mourey E, Michel F, Cormier L

World J Urol. 2014 Oct;32(5):1235-40

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Crehange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT

Cancer Radiother. 2014 Oct;18(5-6):524-34

[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].

Cochet A, Kanoun S, Humbert O, Walker PM, Cormier L, Crehange G, Brunotte F

Cancer Radiother. 2014 Oct;18(5-6):509-16

[Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)].

Cormier L, Bastide C, Beuzeboc P, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Richaud P, Rozet F, Soulie M, Salomon L

Prog Urol. 2014 May;24(6):334-45

Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

Lepinoy A, Cochet A, Cueff A, Cormier L, Martin E, Maingon P, Bosset JF, Brunotte F, Crehange G

Radiother Oncol. 2014 Apr;111(1):120-5

Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.

Pignot G, Salomon L, Neuzillet Y, Masson-Lecomte A, Lebacle C, Patard JJ, Lunardi P, Rischmann P, Pasticier G, Bernhard JC, Cohen J, Timsit MO, Verkarre V, Peyronnet B, Verhoest G, Le Goux C, Zerbib M, Brecheteau F, Bigot P, Larre S, Murez T, Thuret R, Lacarriere E, Champy C, Roupret M, Comperat E, Berger J, Descazeaud A, Toledano H, Bastide C, Lavilledieu S, Avances C, Delage F, Valeri A, Molimard B, Houlgatte A, Gres P, Donnaint A, Kleinclauss F, Legal S, Doerfler A, Koutlidis N, Cormier L, Hetet JF, Colls P, Arvin-Berod A, Rambeaud JJ, Quintens H, Soulie M, Pfister C

Ann Surg Oncol. 2014 Feb;21(2):684-90

[CCAFU Recommendations 2013: Prostate cancer].

Salomon L, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Rozet F, Azria D, Coloby P, Molinie V, Ravery V, Rebillard X, Richaud P, Villers A, Soulie M

Prog Urol. 2013 Nov;23 Suppl 2:S69-101

Total control: a critical analysis of mandatory HIV testing in U.S. prisons.

Gagnon M, Jacob JD, Cormier L

J Forensic Nurs. 2013 Jul-Sep;9(3):154-61

Prostate cancer and optimizing of multidisciplinary care: focus on the RCP and the management of prostate cancer resistant to castration.

Boissier R, Descotes JL, Oudard S, Cormier L, Krakowski I, Houede N, Albiges L

Prog Urol. 2013 Jun;23:7-12.

[Prostate brachytherapy: indications and outcomes].

Hennequin C, Cormier L, Richaud P, Bastide C, Beuzeboc P, Fromont G, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Rozet F, Soulie M, Salomon L

Prog Urol. 2013 May;23(6):378-85

Can we afford prostate permanent seed brachytherapy as monotherapy in Gleason score 7 prostate cancer patients?.

Cormier L, Crehange G

Prog Urol. 2013 Mar;23(1):F12-8.

[Prostate cancer: how do patients choose their treatment?].

Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C

Bull Cancer. 2013 Mar;100(3):191-9

Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.

Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyere F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, Roupret M

World J Urol. 2013 Feb;31(1):61-8

The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.

Ouzzane A, Colin P, Ghoneim TP, Zerbib M, De La Taille A, Audenet F, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguie M, Ruffion A, Roupret M

World J Urol. 2013 Feb;31(1):189-97

Editorial comment.

Cormier L

Urology. 2013 Jan;81(1):134; author reply 134-5

[Erectile function and sexuality of partners after radical prostatectomy with robotics versus manual laparoscopy: long-term assessment].

Deffar N, Koutlidis N, Cormier L

Prog Urol. 2013 Jan;23(1):42-9

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.

Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phe V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, de La Taille A, Saint F, Fais PO, Houlgatte A, Cussenot O, Roupret M

BJU Int. 2012 Dec;110(11 Pt B):E583-9

Robot-assisted or pure laparoscopic nerve-sparing radical prostatectomy: what is the optimal procedure for the surgical margins? A single center experience.

Koutlidis N, Mourey E, Champigneulle J, Mangin P, Cormier L

Int J Urol. 2012 Dec;19(12):1076-81

Anterior suspension combined with posterior reconstruction during robot-assisted laparoscopic prostatectomy improves early return of urinary continence: a prospective randomized multicentre trial.

Hurtes X, Roupret M, Vaessen C, Pereira H, Faivre d'Arcier B, Cormier L, Bruyere F

BJU Int. 2012 Sep;110(6):875-83

[5 alpha-reductase inhibitors and prostate cancer: a statement of the Committee of Cancerology of the French Association of Urology].

Eschwege P, Gaschignard N, Ploussard G, Peyromaure M, Bastide C, Cormier L, Mongiat-Artus P, Rozet F, Fromont G, Hennequin C, Renard-Penna R, Beuzeboc P, Richaud P, Soulie M, Salomon L

Prog Urol. 2012 Sep;22(10):555-60

[Lymphadenectomy and prostate cancer: a statement of the committee of cancerology of the French Association of Urology].

Salomon L, Peyromaure M, Fromont G, Rozet F, Eiss D, Bastide C, Beuzeboc P, Gachignard N, Cormier L, Hennequin C, Mongiat-Artus P, Soulie M

Prog Urol. 2012 Jul;22(9):510-9

Exclusive image-guided IMRT versus radical prostatectomy followed by postoperative IMRT for localized prostate cancer: A matched-pair analysis based on risk groups.

Azelie C, Gauthier M, Mirjolet-Didelot C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Maingon P, Crehange G

J. Clin. Oncol.. 2012 Feb;30(5_suppl):135

MR spectroscopy compared with DW-MRI and DCE-MRI at 3-tesla for the noninvasive prediction of short-term radiation response for patients with localized prostate cancer.

Crehange G, Maingon P, Gauthier M, Cochet A, Martin E, Mirjolet-Didelot C, Cormier L, Bonnetain F, Vignon N, Brunotte F, Walker PM

J. Clin. Oncol.. 2012 Feb;30(5_suppl):122

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Crehange G

Radiat Oncol. 2012 Sep 17;7:158

Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.

Roupret M, Drouin SJ, Larre S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, Bastide C, Cormier L, Durand X, Lunardi P, Rischmann P, Nouhaud FX, Ferlicot S, Patard JJ, Floch AP, Irani J, Peyronnet B, Bensalah K, Poissonnier L, Gres P, Droupy S, Casenave J, Wallerand H, Soulie M, Pfister C

Ann Surg Oncol. 2011 Dec;18(13):3833-8

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyere F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguie M, Ruffion A, Roupret M

Eur Urol. 2011 Dec;60(6):1258-65

[High-risk prostate cancer. Review by the Oncology Committee of the French Urology Association].

Rozet F, Hennequin C, Fromont G, Mongiat-Artus P, Bastide C, Beuzeboc P, Cormier L, Eiss D, Peyromaure M, Richaud P, Salomon L, Soulie M

Prog Urol. 2011 Dec;21(13):901-8

Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.

Crehange G, Maingon P, Gauthier M, Parfait S, Cochet A, Mirjolet C, Bonnetain F, Cormier L, Brunotte F, Walker P

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e407-13

Financial aspects, or how to use robot assistance without losing money. Perspectives from a public hospital.

Cormier L

J Visc Surg. 2011 Oct;148(5 Suppl):e19-21

Transcatheter embolization of a renal artery pseudoaneurysm after open partial nephrectomy.

Guiu B, Kermarrec I, Ladoire S, Cormier L, Ricolfi F

Am J Surg. 2011 Sep;202(3):e25-6

Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.

Crehange G, Parfait S, Liegard M, Maingon P, Ben Salem D, Cochet A, Funes de la Vega M, Cormier L, Bonnetain F, Mirjolet C, Brunotte F, Walker PM

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1087-94

Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study.

Cornu JN, Drouin S, Cancel-Tassin G, Bigot P, Azzouzi AR, Koutlidis N, Cormier L, Gaffory C, Roupret M, Sebe P, Bitker MO, Haab F, Cussenot O

Mol Med. 2011 May-Jun;17(5-6):473-7

Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents.

Ladoire S, Bonnetain F, Gauthier M, Zanetta S, Petit JM, Guiu S, Kermarrec I, Mourey E, Michel F, Krause D, Hillon P, Cormier L, Ghiringhelli F, Guiu B

Oncologist. 2011;16(1):71-81

[Recommendations Onco-Urology 2010: Prostate cancer].

Salomon L, Azria D, Bastide C, Beuzeboc P, Cormier L, Cornud F, Eiss D, Eschwege P, Gaschignard N, Hennequin C, Molinie V, Mongiat Artus P, Moreau JL, Peneau M, Peyromaure M, Ravery V, Rebillard X, Richaud P, Rischmann P, Rozet F, Staerman F, Villers A, Soulie M

Prog Urol. 2010 Nov;20 Suppl 4:S217-51.

Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failure.

Ladoire S, Eymard JC, Zanetta S, Mignot G, Martin E, Kermarrec I, Mourey E, Michel F, Cormier L, Ghiringhelli F

Anticancer Res. 2010 Oct;30(10):4317-23.

[Does robotics improve laparoscopic radical prostatectomy in complex surgical cases?].

Kermarrec I, Mangin P, Koutlidis N, Mourey E, Cormier L

Prog Urol. 2010 Oct;20(9):638-43

[Critic analysis of a comparative meta-analysis on the morbidity, functional and carcinologic results after radical prostatectomy according to surgical approach. Work of cancerology committee of the French urological association].

Bastide C, Rozet F, Salomon L, Mongiat-Artus P, Beuzeboc P, Cormier L, Eiss D, Gaschignard N, Peyromaure M, Richaud P, Soulie M

Prog Urol. 2010 Sep;20(8):547-52

Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage.

Delgal A, Cercueil JP, Koutlidis N, Michel F, Kermarrec I, Mourey E, Cormier L, Krause D, Loffroy R

J Urol. 2010 May;183(5):1947-53

[Erectile function after permanent prostate brachytherapy: A long term prospective study about 157 cases]

Marcon N, Cormier L, Peiffert D, Mangin P

Prog Urol. 2010 Apr;20(4):284-91

[The patient, actor of his route to health]

Cormier L

Rev Infirm. 2010 Mar;(158):21-4.

[Pure laparoscopic versus robotic-assisted laparoscopic radical prostatectomy: comparative study to assess functional urinary outcomes]

Gosseine PN, Mangin P, Leclers F, Cormier L

Prog Urol. 2009 Oct;19(9):611-7

[Study on the quality of life of patients suffering from localized prostate cancer treated with HIFU]

Boudrant G, Mangin P, Feuillu B, Peiffert D, Cormier L

Prog Urol. 2009 Sep;19(8):542-52

Association between estrogen and androgen receptor genes and prostate cancer risk.

Nicolaiew N, Cancel-Tassin G, Azzouzi AR, Grand BL, Mangin P, Cormier L, Fournier G, Giordanella JP, Pouchard M, Escary JL, Valeri A, Cussenot O

Eur J Endocrinol. 2009 Jan;160(1):101-6

Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.

Cussenot O, Azzouzi AR, Bantsimba-Malanda G, Gaffory C, Mangin P, Cormier L, Fournier G, Valeri A, Jouffe L, Roupret M, Fromont G, Sibony M, Comperat E, Cancel-Tassin G

Clin Cancer Res. 2008 Sep 1;14(17):5635-9.

Prostate cancer in renal transplant recipients.

Kleinclauss F, Gigante M, Neuzillet Y, Mouzin M, Terrier N, Salomon L, Iborra F, Petit J, Cormier L, Lechevallier E

Nephrol Dial Transplant. 2008 Jul;23(7):2374-80

Complete robotic-assistance during laparoscopic living donor nephrectomies: an evaluation of 38 procedures at a single site.

Hubert J, Renoult E, Mourey E, Frimat L, Cormier L, Kessler M

Int J Urol. 2007 Nov;14(11):986-9.

How is prostate cancer screenign perceived by men 50 to 70 years of age ? Analysis based on 1,774 screened individuals

Larre S, Azzouzi AR, Cormier L, Cancel-Tassin G, Drelon I, Baschet F, Villette JM, Cussenot O, Mangin P

Prog Urol. 2007 Sep;17(5):939-42.

Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.

Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G

J Clin Oncol. 2007 Aug 20;25(24):3596-602.